Takara Real-time qPCR for COVID-19 research

Takara Real-time qPCR for COVID-19 Research

Citations for SARS-CoV-2 Detection Using Takara Bio RT-PCR Kits

• CDI Enhanced COVID-19 Test EUA Summary, Hackensack University Medical Center (HUMC) Molecular Pathology Laboratory (April 15, 2020)
• COV-19 IDx assay EUA Summary, Ipsum Diagnostics, LLC (April 1, 2020)
• Brown, J. R. et al. Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes. bioRxiv 2020.04.17.047118; doi: 10.1101/2020.04.17.047118
• Reijns, M. AM. et al. A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection. medRxiv 2020.07.14.20154005; doi: 10.1101/2020.07.14.20154005
• Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. NEJMoa2001017 (2020)
  • Zhu et al. supplementary appendix: RT-qPCR protocol and primers used

Related Product Information

For detailed product specifications and available sizes, please visit:

• One Step PrimeScript III RT-qPCR Mix product page
• One Step PrimeScript RT-PCR Kit (Perfect Real Time) product page
• PrimeDirect Probe RT-qPCR Mix product page

Additional Product Information

Please refer to the product’s Certificate of Analysis for details on:

• Storage conditions
• Product components
• Technical specifications

Kit Components Lists and Certificates of Analysis are available under the Documents tab on the product page.

Contact Information

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566
Asia Pacific: +1.650.919.7300
Europe: +33.(0)1.3904.6880
Japan: +81.(0)77.565.6999

Note: FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
© 2023 Takara Bio Inc. All Rights Reserved.
All trademarks are the property of Takara Bio Inc. or its affiliates. Certain trademarks may not be registered in all jurisdictions.
Additional product, intellectual property, and restricted use information is available at takarabio.com.